molecular subtypes in diffuse large b-cell lymphoma
Published 9 years ago • 599 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
2:21
the role of molecular subtyping in dlbcl and implications for treatment decisions
-
7:16
changes in the classification of dlbcl
-
1:12
exciting advances in dlbcl: molecular characterization of subtypes & novel immunotherapeutic agents
-
3:04
applying molecular understanding of dlbcl to management strategies
-
2:27
elucidating the genetic and molecular basis of dlbcl
-
2:29
the management of dlbcl and the importance of characterizing molecular subtypes
-
1:34
molecular-guided treatment of b-cell lymphomas
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
29:38
dlbcl treatment approaches: what you need to know
-
1:41
polarix: r-chp is more effective in the subgroup of dlbcl patients with activated b-cell origin
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
8:41
iwnhl 2015 roundtable: biology of diffuse large b-cell lymphoma
-
2:15
vipor: a multi-targeted therapy for the treatment of r/r dlbcl
-
0:37
the importance of diagnosing dlbcl on a molecular level and how it will improve treatment
-
3:22
the latest data in diffuse large b-cell lymphoma from icml 2017
-
14:40
update on the clinical management of diffuse large b-cell lymphoma
-
1:14
ash 2014: managing diffuse large b-cell lymphoma
-
3:53
racial disparities affecting black patients with diffuse large b-cell lymphoma
-
1:08
the importance of recgonizing different dlbcl subtypes
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl